ResMed ($RMD) podcast mentions
Per Ticker.id: 2 ResMed ($RMD) mentions across 2 podcasts (30 days) — timestamped, verifiable quotes, updated 2026-09-26.
Well said, mate. Let me just double down on that other point you make. It is choosing what to compare yourself with. For me, it's always the business. I'll give you a really neat example because a lot of people will be familiar with it. Let's go back 2 years. And I'm being selective with my dates here, but just to illustrate the point. 2 years ago, you remember all these GLP-1 diet drugs were sort of like really coming into vogue. Anyway, ResMed just ate it. No one was going to use sleep apnea anymore before. But there's plenty of investors I knew that were like, you know, it's kind of still a good business, and maybe they I think that's too simplistic a thesis. And actually, I actually think revenue's going to go up over the next couple of years, and I think profit's going to go up. So, well, let's have a look what happened. Well, revenue went from $7.07 billion in 2024 to $8.2 billion in 2026.
Chris Hill · Motley Fool Money · Mailbag, incl: I didn’t beat the S&P500. Should I give up? September 27, 2026 · 2026-09-26